Work

Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.4046

Authors: Ian Chau, Johanna C. Bendell, Emiliano Calvo, Rafael Santana-Davila, Hendrik-Tobias Arkenau, Gu Mi, Jin Jin, Jessicca Rege, David Ferry, Roy S. Herbst, Charles S. Fuchs

Institutions: Royal Marsden Hospital, Tennessee Oncology, University of Washington, Sarah Cannon Research Institute, Eli Lilly (United States), Yale University

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891835613

Cites:

Cited by: 17

Related to: 10